Point Of Care Hematology Diagnostics Market Report Infographic Image

Published : March 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Point Of Care Hematology Diagnostics Market Report 2026

Name: Point Of Care Hematology Diagnostics Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Type (Complete Blood Count, Coagulation Testing, Hemoglobin Testing, Anemia Diagnosis, Other Types), By Mode Of Prescription (Prescription Based Product, Over-The-Counter Based Product), By End User (Diagnostic Centers, Hospitals, Blood Banks, Transfusion Centers, Other End Users) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Point Of Care Hematology Diagnostics Market Overview

• Point Of Care Hematology Diagnostics market size has reached to $2.9 billion in 2025

• Expected to grow to $4.39 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%

• Growth Driver: Increasing Prevalence Of Blood Disorders Fueling The Growth Of The Market Due To Rising Chronic Disease Incidence And Need For Timely Monitoring

• Market Trend: Artificial Intelligence-Powered Cartridge System Transforms On-Site Blood Analysis

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Point Of Care Hematology Diagnostics Market?

Point of care hematology diagnostics refers to medical tests conducted at or near the site of patient care to quickly assess blood-related conditions, such as anemia, infections, or clotting disorders. These tests provide rapid, accurate hematological results to support timely clinical decisions, especially in emergency or resource-limited settings. This approach reduces the need for centralized laboratory testing and accelerates diagnosis and treatment.

The main types of point-of-care hematology diagnostics are complete blood count, coagulation testing, hemoglobin testing, anemia diagnosis, and others. A complete blood count (CBC) is a blood test that measures various components of blood, including red blood cells, white blood cells, hemoglobin, hematocrit, and platelets, to help evaluate overall health and detect a wide range of disorders. These diagnostics are available in products as consumables and systems. The different modes of prescription include both prescription-based and over-the-counter-based products, catering to various end users such as diagnostic centers, hospitals, blood banks, transfusion centers, and others.

Point Of Care Hematology Diagnostics market report bar graph

What Is The Point Of Care Hematology Diagnostics Market Size and Share 2026?

The point of care hematology diagnostics market size has grown strongly in recent years. It will grow from $2.9 billion in 2025 to $3.16 billion in 2026 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to dependence on centralized laboratory testing, increasing burden of anemia and blood disorders, growth in hospital emergency admissions, need for faster diagnostic turnaround, limited access to laboratory infrastructure in rural areas.

What Is The Point Of Care Hematology Diagnostics Market Growth Forecast?

The point of care hematology diagnostics market size is expected to see strong growth in the next few years. It will grow to $4.39 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to rising prevalence of chronic and infectious diseases, expansion of point of care testing programs, increasing demand for rapid diagnostics in emergency care, technological advancements in compact hematology analyzers, growth in decentralized healthcare delivery models. Major trends in the forecast period include rising adoption of rapid bedside blood testing, growing demand for decentralized diagnostics in emergency settings, increasing use of portable and handheld hematology devices, expansion of point of care testing in resource-limited areas, focus on faster turnaround time for clinical decision-making.

Book your 30 minutes free consultation with our research experts

Global Point Of Care Hematology Diagnostics Market Segmentation

1) By Type: Complete Blood Count, Coagulation Testing, Hemoglobin Testing, Anemia Diagnosis, Other Types

2) By Mode Of Prescription: Prescription Based Product, Over-The-Counter Based Product

3) By End User: Diagnostic Centers, Hospitals, Blood Banks, Transfusion Centers, Other End Users

Subsegments:

1) By Complete Blood Count: White Blood Cell Count, Red Blood Cell Count, Platelet Count, Hematocrit, Hemoglobin Concentration, Mean Corpuscular Volume (MCV)

2) By Coagulation Testing: Prothrombin Time (PT), Activated Partial Thromboplastin Time (aPTT), International Normalized Ratio (INR), D-Dimer Test, Fibrinogen Level

3) By Hemoglobin Testing: Total Hemoglobin, Glycated Hemoglobin (HbA1c), Oxyhemoglobin, Carboxyhemoglobin, Methemoglobin

4) By Anemia Diagnosis: Iron Studies, Vitamin B12 Levels, Folate Levels, Reticulocyte Count, Ferritin Test, Transferrin Saturation

5) By Other Types: Blood Typing And Crossmatching, Erythrocyte Sedimentation Rate, Malaria Parasite Detection, Sickle Cell Screening, C-Reactive Protein Testing

What Is The Driver Of The Point Of Care Hematology Diagnostics Market?

The increasing prevalence of blood disorders is expected to propel the growth of the point-of-care hematology diagnostics market going forward. Blood disorders refer to conditions that affect the components of blood, including red blood cells, white blood cells, platelets, or plasma. The increasing incidence of blood disorders is primarily due to the rising prevalence of chronic diseases, which directly impact blood health and require ongoing monitoring. Point-of-care hematology diagnostics help in the timely detection and monitoring of blood disorders by providing rapid, accurate results at or near the site of patient care, enabling quicker clinical decisions and improved disease management.For instance, in November 2024, according to the The American Society of Hematology a US-based Non-profit organization, projected that global leukemia cases could increase to approximately 519,540 by 2050. Therefore, the rising incidence of blood disorders is driving the growth of the point-of-care hematology diagnostics market.

Key Players In The Global Point Of Care Hematology Diagnostics Market

Major companies operating in the point of care hematology diagnostics market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Sysmex Corporation, HORIBA Ltd., Nova Biomedical Corp., S.D. Sight Diagnostics Ltd., EKF Diagnostics Holdings plc., BioMedomics Inc., PixCell Medical Technologies Ltd., Boule Diagnostics AB, Nihon Kohden Corporation, Edan Instruments Inc., A Menarini Industrie Farmaceutiche Srl, Becton Dickinson and Company, Ortho Clinical Diagnostics, Khema Diagnostics, Bio-Rad Laboratories Inc.

Global Point Of Care Hematology Diagnostics Market Trends and Insights

Major companies operating in the point-of-care hematology diagnostics market are focusing on developing technologically advanced products, such as cartridge-based AI-powered hematology analyzers, to deliver rapid, accurate, and on-site blood analysis for improved patient care. Cartridge-based AI-powered hematology analyzers are compact diagnostic devices that use single-use reagent cartridges and artificial intelligence algorithms to quickly and accurately analyze blood samples at the point of care. For instance, in September 2024, Zoetis Inc., a US-based veterinary health company, launched Vetscan OptiCell, a cartridge-based, AI-powered hematology analyzer designed for veterinary use. This innovative system delivers rapid, reference laboratory-quality complete blood count (CBC) results within minutes at the point of care, while reducing maintenance and hands-on time. It is equipped with advanced AI-driven image analysis and viscoelastic focusing technology that precisely aligns cells for clear imaging, enabling accurate blood cell classification and automated abnormality detection, thereby ensuring efficient and reliable veterinary diagnostics.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Point Of Care Hematology Diagnostics Market?

In June 2023, Mars Inc., a US-based pet company, acquired Heska Corporation for an undisclosed amount. With this acquisition, Mars Inc. aims to expand its veterinary diagnostics capabilities and strengthen its position in advanced animal healthcare through Heska’s innovative diagnostic and specialty solutions. Heska Corporation is a US-based veterinary diagnostics company offering point-of-care (POC) hematology diagnostics.

Regional Outlook

North America was the largest region in the point of care hematology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Point Of Care Hematology Diagnostics Market?

The point of care hematology diagnostics market consists of revenues earned by entities by providing services such as rapid blood testing, decentralized diagnostic solutions, and home-based blood monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The point of care hematology diagnostics market also includes sales of portable hematology analyzers, cartridges and test kits, lancets, and reagents. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Point Of Care Hematology Diagnostics Market Report 2026?

The point of care hematology diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the point of care hematology diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Point Of Care Hematology Diagnostics Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$3.16 billion
Revenue Forecast In 2035	$4.39 billion
Growth Rate	CAGR of 9.0% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Mode Of Prescription, End User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	F. Hoffmann-La Roche Ltd., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Sysmex Corporation, HORIBA Ltd., Nova Biomedical Corp., S.D. Sight Diagnostics Ltd., EKF Diagnostics Holdings plc., BioMedomics Inc., PixCell Medical Technologies Ltd., Boule Diagnostics AB, Nihon Kohden Corporation, Edan Instruments Inc., A Menarini Industrie Farmaceutiche Srl, Becton Dickinson and Company, Ortho Clinical Diagnostics, Khema Diagnostics, Bio-Rad Laboratories Inc.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Point Of Care Hematology Diagnostics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Point Of Care Hematology Diagnostics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Point Of Care Hematology Diagnostics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Point Of Care Hematology Diagnostics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Artificial Intelligence & Autonomous Intelligence

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.4 Biotechnology, Genomics & Precision Medicine

4.1.5 Industry 4.0 & Intelligent Manufacturing

4.2. Major Trends

4.2.1 Rising Adoption Of Rapid Bedside Blood Testing

4.2.2 Growing Demand For Decentralized Diagnostics In Emergency Settings

4.2.3 Increasing Use Of Portable And Handheld Hematology Devices

4.2.4 Expansion Of Point Of Care Testing In Resource-Limited Areas

4.2.5 Focus On Faster Turnaround Time For Clinical Decision-Making

5. Point Of Care Hematology Diagnostics Market Analysis Of End Use Industries

5.1 Diagnostic Centers

5.2 Hospitals

5.3 Blood Banks

5.4 Transfusion Centers

5.5 Primary Healthcare Clinics

6. Point Of Care Hematology Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Point Of Care Hematology Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Point Of Care Hematology Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Point Of Care Hematology Diagnostics Market Size, Comparisons And Growth Rate Analysis

7.3. Global Point Of Care Hematology Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Point Of Care Hematology Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Point Of Care Hematology Diagnostics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Point Of Care Hematology Diagnostics Market Segmentation

9.1. Global Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Complete Blood Count, Coagulation Testing, Hemoglobin Testing, Anemia Diagnosis, Other Types

9.2. Global Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Prescription Based Product, Over-The-Counter Based Product

9.3. Global Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Diagnostic Centers, Hospitals, Blood Banks, Transfusion Centers, Other End Users

9.4. Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Complete Blood Count, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

White Blood Cell Count, Red Blood Cell Count, Platelet Count, Hematocrit, Hemoglobin Concentration, Mean Corpuscular Volume (MCV)

9.5. Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Coagulation Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Prothrombin Time (PT), Activated Partial Thromboplastin Time (aPTT), International Normalized Ratio (INR), D-Dimer Test, Fibrinogen Level

9.6. Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Hemoglobin Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Total Hemoglobin, Glycated Hemoglobin (HbA1c), Oxyhemoglobin, Carboxyhemoglobin, Methemoglobin

9.7. Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Anemia Diagnosis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Iron Studies, Vitamin B12 Levels, Folate Levels, Reticulocyte Count, Ferritin Test, Transferrin Saturation

9.8. Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Blood Typing And Crossmatching, Erythrocyte Sedimentation Rate, Malaria Parasite Detection, Sickle Cell Screening, C-Reactive Protein Testing

10. Point Of Care Hematology Diagnostics Market Regional And Country Analysis

10.1. Global Point Of Care Hematology Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Point Of Care Hematology Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Point Of Care Hematology Diagnostics Market

11.1. Asia-Pacific Point Of Care Hematology Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Point Of Care Hematology Diagnostics Market

12.1. China Point Of Care Hematology Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Point Of Care Hematology Diagnostics Market

13.1. India Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Point Of Care Hematology Diagnostics Market

14.1. Japan Point Of Care Hematology Diagnostics Market Overview

14.2. Japan Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Point Of Care Hematology Diagnostics Market

15.1. Australia Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Point Of Care Hematology Diagnostics Market

16.1. Indonesia Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Point Of Care Hematology Diagnostics Market

17.1. South Korea Point Of Care Hematology Diagnostics Market Overview

17.2. South Korea Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Point Of Care Hematology Diagnostics Market

18.1. Taiwan Point Of Care Hematology Diagnostics Market Overview

18.2. Taiwan Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Point Of Care Hematology Diagnostics Market

19.1. South East Asia Point Of Care Hematology Diagnostics Market Overview

19.2. South East Asia Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Point Of Care Hematology Diagnostics Market

20.1. Western Europe Point Of Care Hematology Diagnostics Market Overview

20.2. Western Europe Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Point Of Care Hematology Diagnostics Market

21.1. UK Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Point Of Care Hematology Diagnostics Market

22.1. Germany Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Point Of Care Hematology Diagnostics Market

23.1. France Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Point Of Care Hematology Diagnostics Market

24.1. Italy Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Point Of Care Hematology Diagnostics Market

25.1. Spain Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Point Of Care Hematology Diagnostics Market

26.1. Eastern Europe Point Of Care Hematology Diagnostics Market Overview

26.2. Eastern Europe Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Point Of Care Hematology Diagnostics Market

27.1. Russia Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Point Of Care Hematology Diagnostics Market

28.1. North America Point Of Care Hematology Diagnostics Market Overview

28.2. North America Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Point Of Care Hematology Diagnostics Market

29.1. USA Point Of Care Hematology Diagnostics Market Overview

29.2. USA Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Point Of Care Hematology Diagnostics Market

30.1. Canada Point Of Care Hematology Diagnostics Market Overview

30.2. Canada Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Point Of Care Hematology Diagnostics Market

31.1. South America Point Of Care Hematology Diagnostics Market Overview

31.2. South America Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Point Of Care Hematology Diagnostics Market

32.1. Brazil Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Point Of Care Hematology Diagnostics Market

33.1. Middle East Point Of Care Hematology Diagnostics Market Overview

33.2. Middle East Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Point Of Care Hematology Diagnostics Market

34.1. Africa Point Of Care Hematology Diagnostics Market Overview

34.2. Africa Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Point Of Care Hematology Diagnostics Market Regulatory and Investment Landscape

36. Point Of Care Hematology Diagnostics Market Competitive Landscape And Company Profiles

36.1. Point Of Care Hematology Diagnostics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Point Of Care Hematology Diagnostics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Point Of Care Hematology Diagnostics Market Company Profiles

36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Shenzhen Mindray Bio-Medical Electronics Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

37. Point Of Care Hematology Diagnostics Market Other Major And Innovative Companies

Sysmex Corporation, HORIBA Ltd., Nova Biomedical Corp., S.D. Sight Diagnostics Ltd., EKF Diagnostics Holdings plc., BioMedomics Inc., PixCell Medical Technologies Ltd., Boule Diagnostics AB, Nihon Kohden Corporation, Edan Instruments Inc., A Menarini Industrie Farmaceutiche Srl, Becton Dickinson and Company, Ortho Clinical Diagnostics, Khema Diagnostics, Bio-Rad Laboratories Inc.

38. Global Point Of Care Hematology Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Point Of Care Hematology Diagnostics Market

40. Point Of Care Hematology Diagnostics Market High Potential Countries, Segments and Strategies

40.1 Point Of Care Hematology Diagnostics Market In 2030 - Countries Offering Most New Opportunities

40.2 Point Of Care Hematology Diagnostics Market In 2030 - Segments Offering Most New Opportunities

40.3 Point Of Care Hematology Diagnostics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Point Of Care Hematology Diagnostics Market, Overview Of Key Products - Product Examples

Table 2: Global Point Of Care Hematology Diagnostics Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Point Of Care Hematology Diagnostics Market, Supply Chain Analysis

Table 4: Global Point Of Care Hematology Diagnostics Market, Major Raw Material Providers

Table 5: Global Point Of Care Hematology Diagnostics Market, Major Resource Providers

Table 6: Global Point Of Care Hematology Diagnostics Market, Major Manufacturers (Suppliers)

Table 7: Global Point Of Care Hematology Diagnostics Market, Major Distributors And Channel Partners

Table 8: Global Point Of Care Hematology Diagnostics Market, Key Technologies & Future Trends

Table 9: Global Point Of Care Hematology Diagnostics Market, Major Trends

Table 10: Global Point Of Care Hematology Diagnostics Market, Major End Users

Table 11: Global Point Of Care Hematology Diagnostics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Point Of Care Hematology Diagnostics Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Point Of Care Hematology Diagnostics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Point Of Care Hematology Diagnostics Market - TAM, US$ Billion, 2025

Table 15: Global Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Complete Blood Count, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Coagulation Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Hemoglobin Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Anemia Diagnosis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Point Of Care Hematology Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Point Of Care Hematology Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Global Point Of Care Hematology Diagnostics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 98: Global Point Of Care Hematology Diagnostics Market - Company Scoring Matrix

Table 99: F. Hoffmann-La Roche Ltd. Financial Performance

Table 100: Abbott Laboratories Financial Performance

Table 101: Danaher Corporation Financial Performance

Table 102: Siemens Healthineers AG Financial Performance

Table 103: Shenzhen Mindray Bio-Medical Electronics Co. Ltd. Financial Performance

Table 104: Global Point Of Care Hematology Diagnostics Market, Competitive Benchmarking (In USD Billions)

Table 105: Global Point Of Care Hematology Diagnostics Market, Competitive Dashboard

Table 106: Global Point Of Care Hematology Diagnostics Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 107: Global, Point Of Care Hematology Diagnostics Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 108: Global, Point Of Care Hematology Diagnostics Market Size Gain ($ Billion), Segmentation By Mode Of Prescription, 2025 – 2030

Table 109: Global, Point Of Care Hematology Diagnostics Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

List Of Figures

Figure 1: Global Point Of Care Hematology Diagnostics Market, Overview Of Key Products - Product Examples

Figure 2: Global Point Of Care Hematology Diagnostics Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Point Of Care Hematology Diagnostics Market, Supply Chain Analysis

Figure 4: Global Point Of Care Hematology Diagnostics Market, Major Raw Material Providers

Figure 5: Global Point Of Care Hematology Diagnostics Market, Major Resource Providers

Figure 6: Global Point Of Care Hematology Diagnostics Market, Major Manufacturers (Suppliers)

Figure 7: Global Point Of Care Hematology Diagnostics Market, Major Distributors And Channel Partners

Figure 8: Global Point Of Care Hematology Diagnostics Market, Key Technologies & Future Trends

Figure 9: Global Point Of Care Hematology Diagnostics Market, Major Trends

Figure 10: Global Point Of Care Hematology Diagnostics Market, Major End Users

Figure 11: Global Point Of Care Hematology Diagnostics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Point Of Care Hematology Diagnostics Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Point Of Care Hematology Diagnostics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Point Of Care Hematology Diagnostics Market - TAM, US$ Billion, 2025

Figure 15: Global Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Complete Blood Count, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Coagulation Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Hemoglobin Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Anemia Diagnosis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Point Of Care Hematology Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Point Of Care Hematology Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Global Point Of Care Hematology Diagnostics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 98: Global Point Of Care Hematology Diagnostics Market - Company Scoring Matrix

Figure 99: F. Hoffmann-La Roche Ltd. Financial Performance

Figure 100: Abbott Laboratories Financial Performance

Figure 101: Danaher Corporation Financial Performance

Figure 102: Siemens Healthineers AG Financial Performance

Figure 103: Shenzhen Mindray Bio-Medical Electronics Co. Ltd. Financial Performance

Figure 104: Global Point Of Care Hematology Diagnostics Market, Competitive Benchmarking (In USD Billions)

Figure 105: Global Point Of Care Hematology Diagnostics Market, Competitive Dashboard

Figure 106: Global Point Of Care Hematology Diagnostics Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 107: Global, Point Of Care Hematology Diagnostics Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 108: Global, Point Of Care Hematology Diagnostics Market Size Gain ($ Billion), Segmentation By Mode Of Prescription, 2025 – 2030

Figure 109: Global, Point Of Care Hematology Diagnostics Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

In-Depth Aerosol Drug Delivery Devices Market Report: Business Trends, Growth Factors, and Forecast to 2029

2025 Analysis: Opportunities and Risks in the Evolving Ambulance Stretchers Market

Industry Forecast: Antimicrobial Resistance Diagnostics Market to Generate $5.82 Billion Revenue by 2029

Emerging Trends and Growth Drivers in the Artificial Intelligence (AI) In Endoscopy Market Through 2029

Latest Market Developments in Aseptic Connectors And Welders Industry: Forecast 2025–2029

Competitive and Market Trend Analysis of Atrial Fibrillation Devices Industry Through 2029

Industry Trends Show Bioabsorbable Surgical Mesh Market Set to Expand at 8.6% CAGR Until 2029

Strategic Report on Biodegradable Hemostat Market: Growth Opportunities and Emerging Challenges

Metal Fabrication Market Report 2026 - Global Outlook – By Type (Cutting, Machining, Welding, Bending), By Material Type (Steel, Aluminum, Other Material Types), By End-Use Industry (Manufacturing, Power And Utilities, C...

Modular and Prefabricated Nonresidential Building Construction Market Report 2026 - Global Outlook – By Type (Standard Metal, Agricultural Metal, Modular Nonmetal, Panelized Precast Nonmetal), By Application (Institution...

Pre-Engineered Buildings Market Report 2026 - Global Outlook – By Structure (Single-story, Multi-story), By Products (Walls, Columns and Beams, Roofs and Floors), By Application (Warehouses and industrial, Commercial, In...

Architectural And Structural Metals Market Report 2026 - Global Outlook – By Type (Plate Work And Fabricated Structural Products, Ornamental And Architectural Metal Products), By Material (Steel, Stainless Steel, Aluminu...

Buildings Construction Market Report 2026 - Global Outlook – By Type (Residential Building Construction, Nonresidential Building Construction ), By Building Type (Smart Buildings, Traditional Buildings ), By End User Sec...

Architectural Metal Coatings Market Report 2026 - Global Outlook – By Resin Type (Polyester, Fluoropolymer, Polyurethane, Other Resins), By Coil Coating (Roofing and Cladding, Wall Panels and Facades, Fascia and Soffits,...

Frequently Asked Questions

How big is the Point Of Care Hematology Diagnostics Market?

The Point Of Care Hematology Diagnostics market was valued at $2.9 billion in 2025, increased to $3.16 billion in 2026, and is projected to reach $4.39 billion by 2030.

What is the Point Of Care Hematology Diagnostics market growth?

The global Point Of Care Hematology Diagnostics market is expected to grow at a CAGR of 8.6% from 2026 to 2035 to reach $4.39 billion by 2035.

Who are the key players in Point Of Care Hematology Diagnostics market?

Some Key Players in the Point Of Care Hematology Diagnostics market Include, F. Hoffmann‑La Roche Ltd., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Shenzhen Mindray Bio‑Medical Electronics Co. Ltd., Sysmex Corporation, HORIBA Ltd., Nova Biomedical Corp., S.D. Sight Diagnostics Ltd., EKF Diagnostics Holdings plc., BioMedomics Inc., PixCell Medical Technologies Ltd., Boule Diagnostics AB, Nihon Kohden Corporation, Edan Instruments Inc., A Menarini Industrie Farmaceutiche Srl, Becton Dickinson and Company, Ortho Clinical Diagnostics, Khema Diagnostics, Bio‑Rad Laboratories Inc. .

What is the anticipated growth trend for the Point Of Care Hematology Diagnostics market?

Major trend in this market includes: Artificial Intelligence-Powered Cartridge System Transforms On-Site Blood Analysis . For further insights on this market. request a sample here

Which region has the most growth potential in the Point Of Care Hematology Diagnostics market?

North America was the largest region in the point of care hematology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point of care hematology diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.